These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24757285)

  • 1. Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation.
    Russi EG; Raber-Durlacher JE; Sonis ST
    Mediators Inflamm; 2014; 2014():518261. PubMed ID: 24757285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers.
    Sonis S; Haddad R; Posner M; Watkins B; Fey E; Morgan TV; Mookanamparambil L; Ramoni M
    Oral Oncol; 2007 Mar; 43(3):289-300. PubMed ID: 16920386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mucositis.
    Sonis ST
    Anticancer Drugs; 2011 Aug; 22(7):607-12. PubMed ID: 21709615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of head and neck cancers: issues for clinical pharmacists.
    Scarpace SL; Brodzik FA; Mehdi S; Belgam R
    Pharmacotherapy; 2009 May; 29(5):578-92. PubMed ID: 19397465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients.
    Otty Z; Skinner MB; Dass J; Collins M; Mooi J; Thuraisingam K; Sabesan S
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):287-92. PubMed ID: 21884441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-related toxicities in older adults with head and neck cancer: A population-based analysis.
    O'Neill CB; Baxi SS; Atoria CL; O'Neill JP; Henman MC; Sherman EJ; Lee NY; Pfister DG; Elkin EB
    Cancer; 2015 Jun; 121(12):2083-9. PubMed ID: 25728057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive altered fractionation radiotherapy and concomitant weekly cisplatin for locally advanced head and neck cancer.
    Boulmay BC; Chera BS; Morris CG; Kirwan J; Riggs CE; Lawson M; Mendenhall WM
    Am J Clin Oncol; 2009 Oct; 32(5):488-91. PubMed ID: 19528791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
    Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
    Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hematologic and mucosal toxicities in head and neck cancer patients undergoing chemoradiotherapy: a comparison of 3D-CRT, IMRT, and helical tomotherapy.
    Kruser TJ; Rice SR; Cleary KP; Geye HM; Tome WA; Harari PM; Kozak KR
    Technol Cancer Res Treat; 2013 Oct; 12(5):383-9. PubMed ID: 23547974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.
    Willey CD; Murphy BA; Netterville JL; Burkey BB; Shyr Y; Shakhtour B; Kish B; Raben D; Chen C; Song JI; Kane MA; Cmelak AJ
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1323-31. PubMed ID: 17289289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiotherapy in elderly patients with advanced head and neck cancer under intensive nutritional support.
    Chang PH; Yeh KY; Huang JS; Chen EY; Yang SW; Wang CH
    Asia Pac J Clin Oncol; 2015 Sep; 11(3):228-35. PubMed ID: 25535674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity antagonists in head and neck cancer.
    Trotti A
    Semin Radiat Oncol; 1998 Oct; 8(4):282-91. PubMed ID: 9873106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
    Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation.
    Onseng K; Johns NP; Khuayjarernpanishk T; Subongkot S; Priprem A; Hurst C; Johns J
    J Altern Complement Med; 2017 Dec; 23(12):957-963. PubMed ID: 28657801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of drug treatments for head and neck cancer.
    Galot R; Machiels JP
    Expert Opin Drug Saf; 2016 Nov; 15(11):1527-1539. PubMed ID: 27561463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma.
    Ahn D; Lee GJ; Sohn JH; Lee JE
    Cancer Med; 2020 Dec; 9(24):9256-9265. PubMed ID: 33073917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in understanding of toxicities of treatment for head and neck cancer.
    Logan RM
    Oral Oncol; 2009 Oct; 45(10):844-8. PubMed ID: 19467918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
    Teknos TN; Grecula J; Agrawal A; Old MO; Ozer E; Carrau R; Kang S; Rocco J; Blakaj D; Diavolitsis V; Kumar B; Kumar P; Pan Q; Palettas M; Wei L; Baiocchi R; Savvides P
    Invest New Drugs; 2019 Aug; 37(4):702-710. PubMed ID: 30569244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.